iDNA-Methyl

iDNA-Methyl predicts DNA methylation sites by combining trinucleotide composition (TNC) and pseudo amino acid components (PseAAC) to identify potential cytosine methylation positions in DNA sequences.

Key Features:

• Trinucleotide Composition (TNC): Uses the TNC of a DNA sequence to capture local nucleotide patterns surrounding cytosine residues relevant to methylation.
• Pseudo Amino Acid Components (PseAAC): Translates DNA sequences into protein representations and computes PseAAC to capture structural information that correlates with methylation potential.
• Dataset Optimization: Employs a dataset-optimizing technique to enhance the training process of predictive models.
• High-throughput Genomic Analysis: Capable of handling large-scale genomic sequence datasets for methylation site prediction.
• Prediction in Uncharacterized Sequences: Identifies potential methylation sites within uncharacterized DNA sequences.

Scientific Applications:

• Epigenetic mechanism investigation: Supports investigation of developmental biology and epigenetic mechanisms by predicting methylation sites.
• Cancer biomarker identification: Assists in identifying potential biomarkers for various cancers based on predicted methylation patterns.
• Drug discovery targeting epigenetic modifications: Facilitates drug discovery efforts aimed at epigenetic modifications by providing candidate methylation sites.
• Gene expression regulation studies: Supports studies of gene expression regulation through mapping of predicted methylation sites.

Methodology:

The method combines trinucleotide composition (TNC) and pseudo amino acid components (PseAAC) via translation of DNA to protein representations, applies a dataset-optimizing technique, and uses rigorous cross-validation with experimentally confirmed datasets.